Bayer faces fast-approaching deadline to settle glyphosate-cancer litigation before new trials begin

bayer

Bayer AG is up against a fast-approaching deadline to settle remaining lawsuits over its Roundup weedkiller or face the prospect of a judge restarting the process of sending the cases to trial.

The judge reaffirmed …. that a Nov. 2 deadline looms as the company reported โ€œsignificant progressโ€ on settlements, having finalized accords to resolve about 44,000 U.S. lawsuits, or about 35% of the more than 125,000 filed and unfiled cases alleging the herbicide causes cancer. In June, it said it had reached agreements in 75% of the cases, or about 94,000, as the centerpiece of an $11 billion comprehensive settlement.

U.S. District Judge Vince Chhabria in San Francisco, who is overseeing about 1,000 unresolved cases, added pressure by telling lawyers he will move at full speed to set trials once the deadline passes. At least one case is ready for trial โ€” if Bayer doesnโ€™t manage to win dismissal of it โ€” and a handful of others could be scheduled quickly ….

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Ken Feinberg, the court-appointed mediator overseeing settlement negotiations, told Chhabria that heโ€™s confident it wonโ€™t be necessary to send any cases to trial. โ€œThey will be settled,โ€ he said.

[In August], Chhabria excoriated the company after some lawyers complained that the company was reneging on deals. The judge said it looked as if Bayer may be manipulating the settlement process to its advantage.

Since then, Bayer has reached an additional 12,000 key settlements on top of the 32,000 it previously disclosed.

Read the original post

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Foodโ€”health harming industries or life-saving innovators?
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.โ€™s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Screenshot-2026-05-12-at-10.05.11-AM
Pro-vaccine โ€œheroโ€ vs. an anti-vax โ€œvillainโ€: โ€˜Bad Vaxxโ€™ video stirs MAHA backlash
ChatGPT Image May 12, 2026, 10_19_00 AM 2
Viewpointโ€” 'Muscular governance': How authoritarianism is surging corporate-linked energy misinformation
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels donโ€™t tell the whole story.
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
images
The never-ending GMO debate: Pros and cons
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.